BNET Industries

Pfizer Inc.

(PFE) is in the Pharma Industry

Market Cap:$148.4B
Last Fiscal Year Sales:$48.4B
  • Public
  • US
Dow Jones Description

Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.

Number of Employees 81,800
Contact Information

235 E 42nd St

New York, New York 10017-5755

www.pfizer.com

(212) 573-2323

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Pfizer Raises Quarterly Dividend 13%, See More Annual Hikes

    12/14/09 - Financial Announcement - View Story

  • Pfizer lifts dividend, yield closer to rivals

    12/14/09 - Stock Split / Dividend - View Story

  • BRIEF: SEC probing insider-trading allegations

    12/11/09 - Merger / Acquisition - View Story

  • Pfizer joins partnership with Calif. firm: Collaboration planned with Crown Bioscience for cancer research

    12/11/09 - Joint Venture / Alliance - View Story

  • Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...

    12/08/09 - Joint Venture / Alliance - View Story

  • Science and Technology: Pfizer to buy Croatian drug patent

    12/07/09 - Joint Venture / Alliance - View Story

  • Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update

    12/04/09 - Joint Venture / Alliance - View Story

  • 'IT boosts efficiency & innovation'

    12/04/09 - Merger / Acquisition - View Story

  • Inspector General Saved Billions in Healthcare This Year

    12/04/09 - Legal Settlement - View Story

  • Survey of Alberta nonprofits shows revenues continue to decline

    12/12/09 - Joint Venture / Alliance - View Story

  • Reportlinker Adds Growth Factors Blood And Tissue - A World Report

    12/02/09 - Joint Venture / Alliance - View Story

  • Market Report -- In Play PFE

    12/14/09 - Merger / Acquisition - View Story

  • Protalix Completes NDA Submission for taliglucerase alfa for the Treatment of Gaucher's Disease

    12/10/09 - Joint Venture / Alliance - View Story

  • Pfizer Inc. PFE JOBS Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M

    12/02/09 - Joint Venture / Alliance - View Story

  • Conservationists salute two corporations

    12/06/09 - Merger / Acquisition - View Story

  • Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV

    11/24/09 - Joint Venture / Alliance - View Story

  • 2009: The Year That Was For Pfizer

    12/08/09 - Financial Announcement - View Story

  • A 2nd Loss for Pfizer in Drug Suits

    11/23/09 - Legal Settlement - View Story

  • Pfizer acquires stem cell therapies assets of Axordia

    11/23/09 - Merger / Acquisition - View Story

News & Analysis

Filter by

human resources and pfizer inc. and pharmaceutical company - All News and Analysis

advertisement
     PFE $18.40 +0.10 (0.55% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 55,491,900
Shares Outstanding 8.07B
Market Cap 148.5B
Year High 18.99
Year Low 11.68
Earnings Per Share 1.20
P/E Ratio 15.33
Dividend 0.64
Yield 3.48
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement
Presented by American Express